115 related articles for article (PubMed ID: 15475445)
41. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors.
Scheie D; Andresen PA; Cvancarova M; Bø AS; Helseth E; Skullerud K; Beiske K
Am J Surg Pathol; 2006 Jul; 30(7):828-37. PubMed ID: 16819324
[TBL] [Abstract][Full Text] [Related]
42. Expression of hypoxia-inducible factor-1alpha: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer.
Aebersold DM; Burri P; Beer KT; Laissue J; Djonov V; Greiner RH; Semenza GL
Cancer Res; 2001 Apr; 61(7):2911-6. PubMed ID: 11306467
[TBL] [Abstract][Full Text] [Related]
43. Cyclooxygenase-2 expression in advanced nasopharyngeal carcinoma--a prognostic evaluation and correlation with hypoxia inducible factor 1alpha and vascular endothelial growth factor.
Chan CM; Ma BB; Hui EP; Wong SC; Mo FK; Leung SF; Kam MK; Chan AT
Oral Oncol; 2007 Apr; 43(4):373-8. PubMed ID: 16979927
[TBL] [Abstract][Full Text] [Related]
44. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors.
Idbaih A; Boisselier B; Marie Y; El Hallani S; Sanson M; Crinière E; Rodero M; Carpentier C; Paris S; Laigle-Donadey F; Ducray F; Hoang-Xuan K; Delattre JY
Cancer Genet Cytogenet; 2007 Sep; 177(2):103-7. PubMed ID: 17854663
[TBL] [Abstract][Full Text] [Related]
45. Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis.
Ino Y; Betensky RA; Zlatescu MC; Sasaki H; Macdonald DR; Stemmer-Rachamimov AO; Ramsay DA; Cairncross JG; Louis DN
Clin Cancer Res; 2001 Apr; 7(4):839-45. PubMed ID: 11309331
[TBL] [Abstract][Full Text] [Related]
46. Lactate dehydrogenase 5 expression in operable colorectal cancer: strong association with survival and activated vascular endothelial growth factor pathway--a report of the Tumour Angiogenesis Research Group.
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL;
J Clin Oncol; 2006 Sep; 24(26):4301-8. PubMed ID: 16896001
[TBL] [Abstract][Full Text] [Related]
47. Loss of CIC and FUBP1 expressions are potential markers of shorter time to recurrence in oligodendroglial tumors.
Chan AK; Pang JC; Chung NY; Li KK; Poon WS; Chan DT; Shi Z; Chen L; Zhou L; Ng HK
Mod Pathol; 2014 Mar; 27(3):332-42. PubMed ID: 24030748
[TBL] [Abstract][Full Text] [Related]
48. Expression of hypoxia-inducible factor-1alpha protein predicts survival in patients with transitional cell carcinoma of the upper urinary tract.
Nakanishi K; Hiroi S; Tominaga S; Aida S; Kasamatsu H; Matsuyama S; Matsuyama T; Kawai T
Clin Cancer Res; 2005 Apr; 11(7):2583-90. PubMed ID: 15814637
[TBL] [Abstract][Full Text] [Related]
49. FISH 1p/19q deletion/imbalance for molecular subclassification of glioblastoma.
Nagasaka T; Gunji M; Hosokai N; Hayashi K; Ikeda H; Ito M; Inao S
Brain Tumor Pathol; 2007; 24(1):1-5. PubMed ID: 18095137
[TBL] [Abstract][Full Text] [Related]
50. Panel review of anaplastic oligodendroglioma from European Organization For Research and Treatment of Cancer Trial 26951: assessment of consensus in diagnosis, influence of 1p/19q loss, and correlations with outcome.
Kros JM; Gorlia T; Kouwenhoven MC; Zheng PP; Collins VP; Figarella-Branger D; Giangaspero F; Giannini C; Mokhtari K; Mørk SJ; Paetau A; Reifenberger G; van den Bent MJ
J Neuropathol Exp Neurol; 2007 Jun; 66(6):545-51. PubMed ID: 17549014
[TBL] [Abstract][Full Text] [Related]
51. Caveolin-1 expression in diffuse gliomas: correlation with the proliferation index, epidermal growth factor receptor, p53, and 1p/19q status.
Barresi V; Buttarelli FR; Vitarelli EE; Arcella A; Antonelli M; Giangaspero F
Hum Pathol; 2009 Dec; 40(12):1738-46. PubMed ID: 19716156
[TBL] [Abstract][Full Text] [Related]
52. α-Internexin in the diagnosis of oligodendroglial tumors and association with 1p/19q status.
Eigenbrod S; Roeber S; Thon N; Giese A; Krieger A; Grasbon-Frodl E; Egensperger R; Tonn JC; Kreth FW; Kretzschmar HA
J Neuropathol Exp Neurol; 2011 Nov; 70(11):970-8. PubMed ID: 22002423
[TBL] [Abstract][Full Text] [Related]
53. Genetic and metabolic predictors of chemosensitivity in oligodendroglial neoplasms.
Walker C; Haylock B; Husband D; Joyce KA; Fildes D; Jenkinson MD; Smith T; Broome J; Kopitzki K; du Plessis DG; Prosser J; Vinjamuri S; Warnke PC
Br J Cancer; 2006 Nov; 95(10):1424-31. PubMed ID: 17031404
[TBL] [Abstract][Full Text] [Related]
54. Progenitor-like traits contribute to patient survival and prognosis in oligodendroglial tumors.
Ng FS; Toh TB; Ting EH; Koh GR; Sandanaraj E; Phong M; Wong SS; Leong SH; Kon OL; Tucker-Kellogg G; Ng WH; Ng I; Tang C; Ang BT
Clin Cancer Res; 2012 Aug; 18(15):4122-35. PubMed ID: 22675171
[TBL] [Abstract][Full Text] [Related]
55. Chromosome 1p allelic loss by fluorescence in situ hybridization is not observed in dysembryoplastic neuroepithelial tumors.
Prayson RA; Castilla EA; Hartke M; Pettay J; Tubbs RR; Barnett GH
Am J Clin Pathol; 2002 Oct; 118(4):512-7. PubMed ID: 12375636
[TBL] [Abstract][Full Text] [Related]
56. Anaplastic oligodendroglial tumors harboring 1p/19q deletion can be successfully treated without radiotherapy.
Iwadate Y; Matsutani T; Shinozaki N; Saeki N
Anticancer Res; 2011 Dec; 31(12):4475-9. PubMed ID: 22199318
[TBL] [Abstract][Full Text] [Related]
57. Allelic loss of chromosome 1p and radiotherapy plus chemotherapy in patients with oligodendrogliomas.
Bauman GS; Ino Y; Ueki K; Zlatescu MC; Fisher BJ; Macdonald DR; Stitt L; Louis DN; Cairncross JG
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):825-30. PubMed ID: 11020580
[TBL] [Abstract][Full Text] [Related]
58. Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p.
Mukasa A; Ueki K; Matsumoto S; Tsutsumi S; Nishikawa R; Fujimaki T; Asai A; Kirino T; Aburatani H
Oncogene; 2002 Jun; 21(25):3961-8. PubMed ID: 12037678
[TBL] [Abstract][Full Text] [Related]
59. Correlation between chromosome 1p/19q status and VEGF mRNA expression in gliomas.
Yang B; Hao XQ; Zeng XW; Ji TL; Pan S; Feng YG
Genet Mol Res; 2016 Jan; 15(1):. PubMed ID: 26909925
[TBL] [Abstract][Full Text] [Related]
60. The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas.
Ngo TT; Peng T; Liang XJ; Akeju O; Pastorino S; Zhang W; Kotliarov Y; Zenklusen JC; Fine HA; Maric D; Wen PY; De Girolami U; Black PM; Wu WW; Shen RF; Jeffries NO; Kang DW; Park JK
J Natl Cancer Inst; 2007 Apr; 99(8):639-52. PubMed ID: 17440165
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
